Impact of Artificial Intelligence‐Assisted Endoscopy on Screening for Upper Gastrointestinal Cancer in a Large‐Scale Health Screening Facility
Digestive Endoscopy · 2026-05 · 38 (5)
DOI: 10.1111/den.70159 ↗At a glance
Journal article in Digestive Endoscopy, published online on 2026-05-01. Written by Chihiro Goto and 10 co-authors. Institution: Department of Gastroenterology, Chiba University, Chiba, Japan. Major MEDLINE topics: Artificial Intelligence, Early Detection of Cancer, Endoscopy, Gastrointestinal, Stomach Neoplasms. Cited 2 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Objectives
Artificial intelligence (AI)‐assisted endoscopy has been developed for the early detection of upper gastrointestinal cancer; however, its clinical effectiveness remains insufficiently evaluated. This study assessed its effectiveness in a health screening facility.
Methods
This retrospective cohort study compared AI‐assisted and non‐AI‐assisted upper gastrointestinal endoscopy at Omiya City Clinic, Japan (April 2021–March 2024). Participants who underwent endoscopy between April 2021 and March 2023 were classified as the non‐AI group, while those examined between April 2023 and March 2024 comprised the AI group. The AI‐assisted system was introduced in April 2023. The primary outcome was cancer detection rate (CDR), with secondary outcomes including biopsy rate and positive predictive value (PPV). Propensity score matching (PSM) was performed for age, sex, alcohol consumption, smoking, Helicobacter pylori infection history, endoscopist experience, and prior‐year endoscopy to minimize bias.
Results
In total, 17,662 were included in the AI group and 32,318 in the non‐AI group. PSM created 17,662 matched pairs. In the AI group, the CDR for gastric cancer (GC) was significantly higher compared to the non‐AI group (0.10% vs. 0.03%, p < 0.05). The biopsy rate was slightly higher in the AI group, with no significant difference, whereas the PPV of biopsy for gastric cancer and esophageal cancer was significantly increased (4.84% vs. 2.16%, p < 0.05).
Conclusions
In a clinical screening setting, AI‐assisted endoscopy significantly improved the CDR of GC and enhanced the PPV of biopsies. These findings highlight AI‐assisted endoscopy as a valuable tool for early GC diagnosis in screening environments.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Gastroenterology, Chiba University, Chiba, Japan.
- Omiya City Clinic, Saitama, Japan.
ORCID profiles: Ryo Nakagawa
Cite
APA
Goto, C., Nakagawa, R., Horio, R., Kurosugi, A., Kaneko, T., Ishikawa, T., Ohta, Y., Taida, T., Okimoto, K., Matsumura, T., & Kato, J. (2026). Impact of Artificial Intelligence‐Assisted Endoscopy on Screening for Upper Gastrointestinal Cancer in a Large‐Scale Health Screening Facility. Digestive Endoscopy, 38(5). https://doi.org/10.1111/den.70159
Vancouver
Goto C, Nakagawa R, Horio R, Kurosugi A, Kaneko T, Ishikawa T, et al. Impact of Artificial Intelligence‐Assisted Endoscopy on Screening for Upper Gastrointestinal Cancer in a Large‐Scale Health Screening Facility. Digestive Endoscopy. 2026;38(5). doi:10.1111/den.70159
BibTeX
@article{Goto2026,
author = {Goto, Chihiro and Nakagawa, Ryo and Horio, Ryosuke and Kurosugi, Akane and Kaneko, Tatsuya and Ishikawa, Tsubasa and Ohta, Yuki and Taida, Takashi and Okimoto, Kenichiro and Matsumura, Tomoaki and Kato, Jun},
title = {Impact of Artificial Intelligence‐Assisted Endoscopy on Screening for Upper Gastrointestinal Cancer in a Large‐Scale Health Screening Facility},
journal = {Digestive Endoscopy},
year = {2026},
volume = {38},
number = {5},
doi = {10.1111/den.70159}
}
EUVIMED